Showing results 11 to 16 of 16
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer Journal:Clinical and Translational Medicine | 2021 | ||
Targeting androgen receptor in BQ323636.1 overexpressing ER+ breast cancer to overcome aromatase inhibitor resistance Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 | ||
Targeting CHK2 to reverse tamoxifen resistance by reducing BQ323636.1 in ER-positive breast cancer Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 | ||
2022 | |||
The NCOR2 Splice Variant as Genomic Biomarker for Breast Cancer Proceeding/Conference:BIT's 17th Annual Congress of International Drug Discovery Science and Technology-2019 (IDDST-2019) | 2019 | ||
The role of BQ323636.1, a novel splice variant of NCOR2, in modulation of oxidative stress in breast cancer Proceeding/Conference:AACR Advances in Breast Cancer Research Special Conference, Hollywood, California | 2017 |